Patents by Inventor Santo Landolfo

Santo Landolfo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extracellular IFI16 as therapeutic agents
    Patent number: 8992930
    Abstract: The present invention relates to the inhibition of the circulating extracellular form of the interferon inducible protein 16 (extracellular IFI16) for the treatment of diseases, particularly autoimmune and/or inflammatory disorders or infective disorders.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: March 31, 2015
    Assignee: University of Piemonte Orientale
    Inventors: Michele Mondini, Silvia Costa, Marisa Gariglio, Santo Landolfo
  • Antipathogenic peptides
    Patent number: 8877738
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 4, 2014
    Assignee: Spiderbiotech S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Lactadherin-derived peptides as antiviral agents
    Patent number: 8673849
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antiviral activity, particularly against integrin-using viruses, more particularly against rotavirus. Further, the present invention refers to compositions comprising said peptidic compounds for medical use or for use as food additives.
    Type: Grant
    Filed: May 31, 2011
    Date of Patent: March 18, 2014
    Assignee: ROTALACTIS Srl
    Inventors: Amedeo Conti, David Lembo, Claudio Fabris, Enrico Bertino, Santo Landolfo
  • LACTADHERIN-DERIVED PEPTIDES AS ANTIVIRAL AGENTS
    Publication number: 20130130970
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antiviral activity, particularly against integrin-using viruses, more particularly against rotavirus. Further, the present invention refers to compositions comprising said peptidic compounds for medical use or for use as food additives.
    Type: Application
    Filed: May 31, 2011
    Publication date: May 23, 2013
    Applicant: ROTALACTIS SRL
    Inventors: Amedeo Conti, David Lembo, Claudio Fabris, Enrico Bertino, Santo Landolfo
  • EXTRACELLULAR IFI16 AS THERAPEUTIC AGENTS
    Publication number: 20130058956
    Abstract: The present invention relates to the inhibition of the circulating extracellular form of the interferon inducible protein 16 (extracellular IFI16) for the treatment of diseases, particularly autoimmune and/or inflammatory disorders or infective disorders.
    Type: Application
    Filed: January 28, 2011
    Publication date: March 7, 2013
    Applicant: Universita degli Studi del Piemonte Orientale "A Avogedro" (University of Piemonte Orientale)
    Inventors: Michele Mondini, Silvia Costa, Marisa Gariglio, Santo Landolfo
  • Antibodies against human cytomegalovirus (HCMV)
    Patent number: 8202518
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: June 19, 2012
    Assignee: Ribovax Biotechnologies S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • NOVEL ANTIPATHOGENIC PEPTIDES
    Publication number: 20120121623
    Abstract: The present invention relates to monomeric and multimeric peptidic compounds which have antipathogenic, in particular antiviral or/and antibacterial activity. In a preferred aspect, the peptide compounds of the invention have an activity in respect of a broad spectrum of viruses, both DNA and RNA viruses, irrespective of whether they possess virus envelope or not. Further, the present invention refers to compositions comprising said peptidic compounds for medical use, i.e. for the treatment or prevention of pathogenic, in particular viral or/and bacterial infections.
    Type: Application
    Filed: August 5, 2010
    Publication date: May 17, 2012
    Applicant: SPIDERBIOTCH S.r.L.
    Inventors: Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo, Giorgio Gribaudo, David Lembo, Davide Gibellini
  • Antibodies against human cytimegalovirus (HCMV)
    Patent number: 8153129
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Grant
    Filed: December 17, 2007
    Date of Patent: April 10, 2012
    Assignee: Ribovax Biotechnologies S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • DETECTION OF IFI16 IN BODY FLUIDS
    Publication number: 20110300529
    Abstract: The present invention relates to methods for the qualitative and/or quantitative determination of interferon inducible protein 16 (IFI 16) in an extracellular form.
    Type: Application
    Filed: December 14, 2009
    Publication date: December 8, 2011
    Applicant: NoToPharm srl
    Inventors: Michele Mondini, Santo Landolfo, Marisa Gariglio, Silvia Costa, Erica Miraglia, Francesca Gugliesi
  • Antibodies Against Human Cytomegalovirus (HCMV)
    Publication number: 20110171233
    Abstract: The present invention provides novel antibodies sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: July 31, 2008
    Publication date: July 14, 2011
    Applicant: RIBOVAX BIOTECHNOLOGIES S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • Antibodies Against Human Cytomegalovirus (HCMV)
    Publication number: 20100284916
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: June 30, 2008
    Publication date: November 11, 2010
    Applicant: RIBOVAX BIOTECHNOLOGIES S.A.
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo
  • DIFFERENTIAL DIAGNOSIS FOR SCLERODERMA
    Publication number: 20100105086
    Abstract: Use of IFI16 protein, fragments or peptides thereof for differential diagnosis of the limited cutaneous form of scleroderma (Ic-SSc) in a subject suspected of or at risk of having an autoimmune disease and the corresponding method of diagnosis and kit.
    Type: Application
    Filed: August 20, 2007
    Publication date: April 29, 2010
    Inventors: Santo Landolfo, Michele Mondini, Marisa Gariglio
  • Antibodies against Human Cytimegalovirus (HCMV)
    Publication number: 20100040602
    Abstract: The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.
    Type: Application
    Filed: December 12, 2007
    Publication date: February 18, 2010
    Applicant: RIBOVAX BIOTECHNOLOGIES SA
    Inventors: Ada Funaro, Giorgio Gribaudo, Santo Landolfo